Announcements Trials

Browse Landscape

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 141 Lung Neoplasms 51 Pancreatic Neoplasms 30 Non-Squamous Non-Small Cell Lung Cancer 18 Neoplasms 15 Adenocarcinoma of Lung 14 Head and Neck Neoplasms 13 Glioblastoma 13 Gliosarcoma 12 Breast Neoplasms 11 Brain Neoplasms 11 Neoplasm Metastasis 9 Carcinoma, Hepatocellular 9 Adenocarcinoma, Bronchiolo-Alveolar 9 Squamous Cell Carcinoma of Head and Neck 8 Carcinoma, Squamous Cell 7 Carcinoma, Renal Cell 7 Astrocytoma 6 Oligodendroglioma 5 Carcinoma 5 Urinary Bladder Neoplasms 4 Liver Neoplasms 4 Glioma 4 Esophageal Neoplasms 4 Colorectal Neoplasms 4 Adenocarcinoma 4 Recurrence 3 Rectal Neoplasms 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3

Interventions

Cisplatin 13 Radiotherapy, Intensity-Modulated 11 Radiotherapy 5 Carboplatin 5 Radiation 4 Cetuximab 4 durvalumab 3 Platinum 3 Nivolumab 3 1,2-diaminocyclohexaneplatinum II citrate 3 pembrolizumab 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Specimen Handling 2 Restraint, Physical 2 Paclitaxel 2 Fluorodeoxyglucose F18 2 Cyclophosphamide 2 Bupropion 2 Biopsy 2 Acupuncture Therapy 2 veliparib 1 utomilumab 1 sodium thiosulfate 1 ficlatuzumab 1 dehydroftorafur 1 Varenicline 1 Transcutaneous Electric Nerve Stimulation 1 Tobacco Use Cessation Devices 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oropharyngeal Neoplasms × Erlotinib Hydrochloride × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡